Combination Oral Medicines
Brand Name (Generic Name)
Actoplus Met (pioglitazone metformin)
Warning: pioglitazone, which is a component of Actoplus Met, may be associated with an increased risk of bladder cancer in some patients after using Actos for more than one year. For more information on side effects, refer to the pioglitazone and metformin sections.
Avandamet (rosiglitazone maleate metformin hydrochloride)
Warning: rosiglitazone, which is a component of Avandamet, can cause or worsen congestive heart failure in some patients. Due to the side effects, Avandamet is now only available to patients who enroll in a special program. Talk to your doctor to get more information on the program. For more information on side effects, refer to the rosiglitazone and metformin sections.
Avandaryl (rosiglitazone glimepiride
A combination of rosiglitazone maleate and glimepiride approved for use in the management of type 2 diabetes. For more information, refer to the rosiglitazone and sulfonylureas sections.
Duetact (pioglitazone glimepiride)
A combination of glimepiride and pioglitazone, two oral diabetes medicines that help control blood sugar levels. For more information, refer to the pioglitazone and sulfonylureas sections.
Glucovance (glyburide metformin hydrochloride)
A combination of glyburide and metformin hydrochloride approved for use in the management of type 2 diabetes in conjunction with diet and exercise. For more information on side effects, refer to the glyburide and metformin sections.
Juvisync (sitagliptin and simvastatin)
A combination of simvastatin and sitagliptin that reduces levels of "bad" cholesterol while increasing levels of "good" cholesterol. For more information on side effects, see DPP-IV Inhibitors and Simvastatin.
Kombiglyze XR (saxagliptin/metformin)
Once-a-day metformin extended-release (XR) plus saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet. For more information, see DPP-IV Inhibitors and biguanides.
PrandiMet (repaglinide metformin HCl tablets)
A meglitinides and biguanides combination drug approved for use as an adjunct to diet and exercise in type 2 diabetes patients when response to repaglinide or metformin monotherapy is inadequate. For more information, refer to the meglitinide and biguanides sections.
Reviewed by James A. Bennett 5/13
Mustard-Garlic Lamb Chops No-Bake Strawberry Cheesecakes Toasty Pizza Rounds Wild Rice with Sunflower Seeds Mini Spanakopita Pea Pods and Onions Pear Salad Steamed Swiss Chard With Tomatoes Tangy Cherry Coleslaw Easy Zesty Salsa
I was up way too late last night. Stressing myself out – or moreover letting a situation get the better of me. I had had a great work out, I’d run and did a leg and ab circuit that left me feeling great. Then I got home to my quiet house, where the events of the past day started noisily playing dodgeball in my brain. With running combined with weight training, I typically drop directly after the work out and then about six hours later, I have to test again to be sure whatever protein I...